ACRV vs EPAM · $65.1M cap vs P/E 14, rev $2.81B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
ACRV currently screens at market cap $65.1M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the ACRV and EPAM stock pages for the full models.
Not investment advice.